openPR Logo
Press release

Benehealth Expands Functional Medicine Approach with Natural Alternatives to GLP-1 Medications

01-29-2025 06:10 PM CET | Fashion, Lifestyle, Trends

Press release from: ABNewswire

Benehealth Expands Functional Medicine Approach with Natural

Benehealth Wellness & Aesthetics in Surprise, AZ, introduces natural alternatives to GLP-1 medications for sustainable weight loss. Their holistic approach focuses on addressing root causes like hormonal imbalances and metabolic dysfunction. With personalized nutrition plans, advanced biometric tracking, and ongoing support, clients achieve lasting results without pharmaceuticals or their side effects. Discover a smarter path to weight loss at Benehealth.
Surprise, AZ - Benehealth Wellness & Aesthetics is enhancing its commitment to patient-centered care by offering natural, science-backed alternatives to GLP-1 medications for those seeking long-term metabolic health solutions. With the addition of Wanda Ichiriu, PA-C, IFMCP, a functional medicine specialist with extensive experience in nephrology and chronic disease management, Benehealth continues to provide holistic pathways for sustainable health.

GLP-1 receptor agonists have gained popularity as a pharmaceutical intervention for metabolic conditions, but many patients face challenges with long-term use and discontinuation. Benehealth's approach focuses on helping individuals transition off these medications safely while maintaining their progress through personalized, functional medicine strategies.

"Functional medicine allows us to go beyond symptom management and address the root causes of metabolic imbalances," said Dr. Tanya Carroccio, DNP, founder of Benehealth Wellness & Aesthetics. "With Wanda's expertise, we are further strengthening our ability to guide patients toward lasting health without over-reliance on pharmaceuticals."

At Benehealth, Wanda will specialize in:

* Alternatives to GLP-1 Medications: Supporting patients in achieving metabolic balance naturally.
* Weaning Off GLP-1s: Providing tailored strategies to transition safely while preserving results.
* Long-Term Health Strategies: Addressing hormonal imbalances, gut health, and inflammation to promote sustained well-being.

By integrating advanced diagnostic tools with functional medicine principles, Benehealth empowers patients to take control of their health with sustainable, individualized care.

For more information or to schedule a consultation, visit http://benehealth.com or contact Benehealth Wellness & Aesthetics today.

Media Contact:

Benehealth Wellness & Aesthetics

Media Contact
Company Name: Benehealth
Contact Person: Dr. Tanya Carroccio, DNP
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=benehealth-expands-functional-medicine-approach-with-natural-alternatives-to-glp1-medications]
Phone: (623) 440-5816
Address:16952 W Bell Rd #304
City: Surprise
State: AZ
Country: United States
Website: https://benehealth.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Benehealth Expands Functional Medicine Approach with Natural Alternatives to GLP-1 Medications here

News-ID: 3840273 • Views:

More Releases from ABNewswire

Actinium Pharmaceuticals Advances Trop-2 Targeted Alpha Radiotherapy Into Phase 1/2 Trials in the U.S. and Australia
Actinium Pharmaceuticals Advances Trop-2 Targeted Alpha Radiotherapy Into Phase …
Actinium Pharmaceuticals (NYSE American: ATNM) is advancing its Trop-2-targeted ATNM-400 construct into Phase 1/2 trials across the United States and Australia, marking an important step as the company broadens its presence in solid-tumor radiopharmaceuticals. With targeted alpha radiotherapy gaining momentum worldwide, the program reinforces Actinium's position as one of the more established players developing actinium-225-based therapeutics for treatment-resistant and late-stage cancers. Why Trop-2 Remains One of Oncology's Most Valuable Targets Trop-2 has
Mucopolysaccharidosis Type I Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | BioMarin Pharma, Sanofi, Orchard Therapeutics, Kyowa Kirin, JCR Pharma, Nippon Shinyaku
Mucopolysaccharidosis Type I Market Dynamics Indicate Upward Trajectory Through …
The Key Mucopolysaccharidosis Type I Companies in the market include - BioMarin Pharmaceutical, Sanofi, Orchard Therapeutics, Kyowa Kirin, JCR Pharmaceuticals, Nippon Shinyaku, Immusoft, Genevector Biotechnology, EdiGene Inc., REGENXBIO, Sigilon Therapeutics, Paradigm Biopharma, Jupiter Neurosciences, and others. DelveInsight's "Mucopolysaccharidosis Type I Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Mucopolysaccharidosis Type I, historical and forecasted epidemiology as well as the Mucopolysaccharidosis Type I market trends in the
United Chimney Services Shares Essential Fireplace Safety Tips for Clifton Homeowners
United Chimney Services Shares Essential Fireplace Safety Tips for Clifton Homeo …
United Chimney Services, serving Clifton and surrounding New Jersey communities, is sharing expert fireplace safety tips as winter increases fire and smoke-related risks. Owner Daniel Ward encourages homeowners to schedule inspections, remove creosote buildup, check ventilation, and practice safe fireplace use to reduce preventable hazards. United Chimney Services is urging Clifton homeowners to prioritize fireplace safety this winter as colder weather increases the risk of chimney fires, smoke damage, and carbon
KinClub Launches New Interactive Kids Magazine, Debuting With a Holiday Issue That Helps Families Slow Down and Connect
KinClub Launches New Interactive Kids Magazine, Debuting With a Holiday Issue Th …
December 11, 2025 - New York, NY - Kinovate Ventures, Inc. today announced the launch of KinClub Magazine, a dynamic new digital publication designed to engage children through a vast library of interactive pages and adaptive learning experiences. The magazine officially debuts with its first major release, the KinClub Holiday Issue [https://magazine.kin-club.com/the-holiday-season-2025], now available for free. Key features of the KinClub Magazine experience include: * A Blend of Classic & Creative: The content

All 5 Releases


More Releases for Benehealth

Benehealth Welcomes Wanda Ichiriu, PA-C, IFMCP, to the Team
Benehealth Wellness & Aesthetics welcomes Wanda Ichiriu, PA-C, IFMCP, a seasoned practitioner with over 20 years of expertise in nephrology and chronic kidney disease management, to its team. Wanda specializes in functional medicine, addressing root causes of chronic conditions like CKD, metabolic disorders, and autoimmune issues. Her holistic approach aligns perfectly with Benehealth's mission of empowering patients to achieve sustainable health and wellness. Surprise, AZ - Benehealth Wellness & Aesthetics proudly
Benehealth Introduces Paramedical Tattooing to Aid in Physical and Emotional Hea …
Benehealth now offers paramedical tattooing, including scar camouflage and areola tattooing, to support clients' physical and emotional recovery post-surgery or trauma. Led by Dr. Tanya Carroccio, DNP, each session is customized for a compassionate, holistic healing experience. As the only provider in the North and West Valley blending paramedical tattooing with functional medicine, Benehealth is dedicated to helping clients regain confidence through a unique approach to wellness. Phoenix, AZ - Benehealth
Health Insurance Market: Surpassing USD 2.65 Trillion by 2030 with a 4.6% CAGR, …
Discover a detailed exploration of the Health Insurance Market by Data Bridge Market Research, thoughtfully presented with visual finesse to ensure seamless data absorption. Crucial insights are illuminated through vivid graphs, charts, and figures, empowering astute decision-making. Global health insurance market which was USD 1,855.30 billion in 2022, and is expected to reach USD 2,658.69 billion by 2030, and is expected to undergo a CAGR of 4.6% during the forecast period The